AJANTA PHARMA BUYBACK 2020 Details: BUY BACK PRICE & RECORD DATE Latest News

Ajanta Pharma BUYBACK 2020 | LATEST Ajanta Pharma SHARE NEWS | Ajanta Pharma BUY BACK RECORD DATE | Ajanta Pharma BUYBACK PRICE | Latest Buybacks News

The board of Ajanta Pharma on Tuesday approved a proposal to buyback ₹135.97 crore worth shares.

Accordingly the company plans to buyback 7.35 lakh shares (representing 0.84 per cent of the total paid-up share capital) at ₹1,850 a share.

The board has fixed November 13 as the record date for determining the eligible shareholders to participate in the buyback. Shares of Ajanta Pharma closed ₹1,609.95 on the BSE.

Ajanta Pharma Share Buyback Offer Details

Ajanta Pharma Share Buy Back Plan | Ajanta Pharma Buyback Shares

Buyback Type: Tender Offer
Ajanta Pharma Buyback Record Date: Nov 13 2020
Ajanta Pharma Buyback Offer Amount: ₹ 135
Date of Board Meeting approving the proposal: Nov 03 2020
Date of Public Announcement: Nov 03 2020
Ajanta Pharma Buyback Offer Size: 0.84%
Buyback Number of Shares: 7,35,000
Price Type: Tender Offer
Face Value (FV): 2
Ajanta Pharma Buyback Price: ₹ 1850 Per Equity Share
Ajanta Pharma Buyback Premium: 20%

Can I Invest today to participate in Ajanta Pharma buyback offer? : Yes

The Board of Directors of Ajanta Pharma Ltd, at its meeting held on 3rd November 2020, have unanimously approved the proposal to buyback its fully paid-up equity shares of Rs. 2/- (Rupees Two only) each not exceeding 7,35,000 (Seven Lakhs Thirty-Five Thousand only) equity shares (representing 0.84% of the total number of equity shares in the paid-up share capital of the Company) at a price of Rs. 1,850/- (Rupees One Thousand Eight Hundred and Fifty only) per equity share.

Also Check:- Ajanta Pharma Dividend 2020

Ajanta Pharma Q2 Results

Ajanta Pharma Consolidated September 2020 Net Sales at Rs 715.91 crore, up 11.38% Y-o-Y.

Net Sales at Rs 715.91 crore in September 2020 up 11.38% from Rs. 642.76 crore in September 2019.

Quarterly Net Profit at Rs. 170.22 crore in September 2020 up 46.29% from Rs. 116.36 crore in September 2019. EBITDA stands at Rs. 279.10 crore in September 2020 up 46.23% from Rs. 190.86 crore in September 2019.

Ajanta Pharma EPS has increased to Rs. 19.51 in September 2020 from Rs. 13.34 in September 2019.

Also Check:- Latest Share Buyback 2020

Upcoming Buyback 2020

INVESTOR ACADEMY 📊 is now on Telegram. Click here to join our channel and stay updated with the Latest Dividends, IPOs news and stock market updates.

Ajanta Pharma Buyback Important Dates

In this section we have covered all important dates related to “Ajanta Pharma Buyback Date”. Dates are updated as they are announced. The most noted dates are Ajanta Pharma record date and Ajanta Pharma buyback open and close dates, which one should use to participate in buyback.

Ajanta Pharma Buyback Offer Dates
Buyback Activity Date
Board Meeting for Ajanta Pharma Buyback proposal 03.11.2020
Ajanta Pharma Buyback Approval date 03.11.2020
Public Announcement of Ajanta Pharma Buyback 03.11.2020
Ajanta Pharma Buyback Record Date 13.11.2020
Ajanta Pharma Buyback opens on/Buyback Opening Date Coming Soon
Ajanta Pharma Buyback closes on/Buyback Closing Date Coming Soon
Cut-off date to receive completed tender forms by Registrar Coming Soon
Cut-off date for verification by the Registrar Coming Soon
Cut-off date to inform Stock Exchange on acceptance or non-acceptance of tendered Equity Shares by Registrar Coming Soon
Last date of settlement of bids on the stock exchange Coming Soon
Last date to return unaccepted shares by Registrar Coming Soon
Last date of extinguishment of Equity Shares Coming Soon

Ajanta Pharma Share Holding Pattern as of SEP 2020

Stock Holding table gives a clear picture on retail investor holdings of Ajanta Pharma shares which helps investor to decide on participating in buyback offer. The less number of retail holdings means higher chance of acceptance in Ajanta Pharma buyback under retail category which is equal to higher profit.

Shareholding Pattern – Ajanta Pharma Ltd.
 
Holder’s Name No of Shares % Share Holding
No Of Shares 8,72,66,770 100%
Promoters 6,15,28,601 70.51%
Foreign Institutions 67,17,114 7.71%
N Banks Mutual Funds 8669400 9.93%
Central Govt 655215 0.75%
Others 892897 1.02%
General Public 7475036 8.57%
Financial Institutions 1309183 1.5%

Ajanta Pharma Buyback Record Date

Tentative Record Date To Participate In Ajanta Pharma Buyback

The company has fixed 13 November, 2020 as the record date for the purpose of ascertaining the eligibility of shareholders for buyback of equity shares.

Ajanta Pharma Buyback Acceptance Ratio

Profit from the buyback on the bases of acceptance Ratio:

Buy 108 Shares at CMP of Rs.1620 ( 2,00,000/1850=108)

Acceptance Ratio 33% 50% 75% 100%
Amount Invested in Buyback 199800 199800 199800 199800
No. of Shares buyback 36 54 81 108
Buyback Profit 8197 12420 18630 24840
Profit 4.10% 6.22% 9.32% 12.43%

How to Apply for Ajanta Pharma Buyback?

Now if you are wondering ‘how do I apply for a buyback?’ we’ve got you covered. When it comes to share-buyback schemes, the capital market regulator has compulsorily reserved a buyback portion of 15% for retail investors who possess in-hold shares in a company worth upto ₹2 lakhs.

This percentage is also taking into account the scrip’s market value as seen on the record date of the buyback offer. During the application process of share buyback, you will be given a tender form by the company.

This form is where you enter the number of shares of that company that you wish to tender. There is a ratio of acceptance attached to the tender form which signifies how likely the company is to accept your request for share buybacks.

Different companies have different ratios for share buybacks. Here is what you can expect in a typical tender form given by a company. There are normally three fields as follows:

  1. The number of shares you hold from the said company as on the record date
  2. The number of shares that fit the eligibility criteria for buybacks
  3. The number of shares that one is applying for a buyback.

Apply Ajanta Pharma buyback from Zerodha

Here is complete method from Zerodha You can apply for Buybacks on Console> Portfolio> Corporate action order window

  • Hover your mouse on the stock and select ‘Options’ and click on ‘Place order’
  • Enter the number of shares you want to tender and click on ‘Submit’
  • Buyback/Takeover/Delisting orders are collected until 6:00 PM, one trading day prior to the offer end date. Ensure to hold sufficient quantities in your demat account before closure of the offer end date. (Do not sell the shares after placing the order). Only shareholders who hold the shares as on the record date will be eligible for the corporate action.

Latest & Upcoming Buybacks 2020

About Ajanta Pharma

Ajanta Pharma is a specialty pharmaceutical company engaged in development, manufacturing and marketing of quality finished dosages.

Committed to ‘Serve Health Care Needs Worldwide’, we produce a comprehensive range of specialty products targeting different therapeutic segments for treatment of patients, customized to each market we are present in.

We clearly understand our customer’s needs and use cutting edge technology to present innovative solutions. Our business includes Branded Generics in emerging markets of Asia and Africa, Generics in the developed markets of USA and Institution sales.

Ajanta Pharma Financial

Salient financial parameters:

Particulars (Cr) Mar-15 Mar-16 Mar-17 Mar-18 Mar-19 Mar-20
Sales 1,474 1,749 1,983 2,126 2,055 2,588
Expenses 969 1,161 1,292 1,467 1,489 1,904
Operating Profit 504 589 691 658 567 683
OPM % 34% 34% 35% 31% 28% 26%
Other Income 9 20 20 24 21 88
Interest 6 5 1 0 1 12
Depreciation 52 44 61 60 72 96
Profit before tax 456 559 648 623 514 664
Tax % 32% 26% 22% 25% 25% 30%
Net Profit 310 416 507 469 387 468
EPS in Rs 35.25 47.23 57.59 53.25 44.35 53.6
Dividend Payout % 17% 17% 23% 0% 20% 24%

Source: Screener.in

Ajanta Pharma Limited – Registrar to the Buyback

LINK INTIME INDIA PRIVATE LIMITED
C-101, 1st Floor, 247 Park, L.B.S Marg, Vikhroli (West),
Mumbai 400 083 Maharashtra, India
Contact Person: Mr. Sumeet Deshpande
Tel: +91 22 4918 6200
Fax: +91 22 4918 6195
E-mail: ajantapharma.buyback@linkintime.co.in
Website: www.linkintime.co.in
SEBI Registration Number: INR000004058;
Validity Period: Permanent
CIN: U67190MH1999PTC118368

Ajanta Pharma Limited Contact Details

Company Contact Details
AJANTA PHARMA LIMITED
Registered & Corporate Office: ‘Ajanta House’, 98 Govt Industrial Area, Charkop,
Kandivli (West), Mumbai – 400 067, Maharashtra, India
CIN: L24230MH1979PLC022059
Contact Person: Mr. Gaurang Shah, Company Secretary
Tel: +91 22 6606 1000 | Fax: +91 22 6606 1200
Email: investorgrievance@ajantapharma.com | Website: www.ajantapharma.com

***Related Queries***

Ajanta Pharma Buyback Important dates – Record Date, Buyback Start and End date. Buyback Details – Buyback Price, Buyback Offer Size, Buyback Number of Shares, Retail Investors limit. What is the record date for Ajanta Pharma buyback?

How can I apply in Ajanta Pharma Buyback offer? Ajanta share buyback, Ajanta Pharma share buyback news, Ajanta Pharma share latest news, Ajanta Pharma share news, Ajanta Pharma share price today, Ajanta Pharma share price, Ajanta Pharma stock latest, Ajanta Pharma share target, Ajanta Pharma share latest target , Ajanta Pharma November 4 , Ajanta Pharma buyback, Ajanta Pharma buyback date, Ajanta Pharma buyback important date, Ajanta Pharma buyback, Ajanta Pharma share news.

Ajanta Pharma Buyback 2020 FAQs:

When is Ajanta Pharma Buyback Record Date?

Ajanta Pharma buyback 2020 record date is Nov 13, 2020.

When is Ajanta Pharma Buyback announcement Date?

Ajanta Pharma buyback 2020 announcement date is Nov 3, 2020.

What is Ajanta Pharma Buyback Price?

The company has fixed the price at ₹1,850 a share

How to apply for Ajanta Pharma Buyback 2020?

As per the Ajanta Pharma record date you need to have Ajanta Pharma shares in your demat account. You can participate in buyback after having the stock in your account.

What is the record date for Ajanta Pharma buyback offer?

The Record Date for Ajanta Pharma Buyback offer: The company has fixed 13 November, 2020 as the record date for the purpose of ascertaining the eligibility of shareholders for buyback of equity shares.

How much I can make with Ajanta Pharma buyback offer?

You can earn a premium of 20% from current market price.
Its all depend on acceptance ratio which usually announce with Letter of Offer. The percentage of proportionate acceptance varies from company to company. This percentage can be also 100% which means that company buys all of your shares.

How to Participate in Ajanta Pharma buyback offer?

Steps to participate in Ajanta Pharma buyback:
On Record date (13.11.2020) you must have share of Ajanta Pharma in your demat account. Depositing of share in your DP account usually take T+2 days, so you need to plan your buying accordingly.
After that company announces buyback open and close window, so you need to tender your share in buyback process. You can do this online or contact your broker to tender your share in buyback, so he can place a request on your behalf.
Next step is with registrar – depend on buyback acceptance ratio, your shares will be sold in buyback process and fund will directly debited in your bank account. Any rejected share will be revert in your demat account which you can sell in open market or hold for long term gain.

How many Ajanta Pharma share are eligible for buyback?

Share holders who hold less than 2 lakh worth of shares are consider in Retail Category. All others will consider in General Category. Last trading price on record date will be used to calculate the eligibility criteria.

When I need to tender Ajanta Pharma share for buyback?

Buyback opening date for Ajanta Pharma: (Coming Soon) Buyback closing date for Ajanta Pharma: (Coming Soon) This is the window when you need to submit your application for proposal for share buyback.

When I will know how much shares accepted in Ajanta Pharma buyback offer?

As this is a buyback tender offer, shares are accepted in proportionate basis. Proportionate acceptance / rejection will be returned back to the eligible shareholders directly by the Registrar on or before (Coming Soon).

LEAVE A REPLY

Please enter your comment!
Please enter your name here